Local clinicians recommend the Bowen's Disease clinical guidance provided by the Primary Care Dermatology Society.
Please always refer to the BNSSG Formulary for the latest prescribing guidance.
If uncertainty, then an excision or biopsy in primary care can confirm the diagnosis.
If not available in primary care this can be done in the Sirona Community Dermatology Service. Alternatively advice can be obtained via the Teledermatology service.
If SCC is suspected then refer under the 2WW rule.
Invasive squamous cell carcinoma proceeds from approximately 3-5% of intra-epidermal squamous cell carcinoma.
Information for Health Care Professionals and Patient information leaflets provided by British Association of Dermatology (BAD):
https://academic.oup.com/bjd/article/188/2/186/6788751?login=false
Information for Health Care Professionals provided by DermnetNZ:
dermnetnz.org/topics/intraepidermal-squamous-cell-carcinoma/
Information for Health Care Professionals on skin cancers recognition and referral, provided by National Institute for Health and Care Excellence:
cks.nice.org.uk/skin-cancers-recognition-and-referral#!scenario
Efforts are made to ensure the accuracy and agreement of these guidelines, including any content uploaded, referred to or linked to from the system. However, BNSSG ICB cannot guarantee this. This guidance does not override the individual responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or guardian or carer, in accordance with the mental capacity act, and informed by the summary of product characteristics of any drugs they are considering. Practitioners are required to perform their duties in accordance with the law and their regulators and nothing in this guidance should be interpreted in a way that would be inconsistent with compliance with those duties.
Information provided through Remedy is continually updated so please be aware any printed copies may quickly become out of date.